Product correctly added to cart.

discount label
Ticagrelor acetate
View 3D

Biosynth logo

Ticagrelor acetate

CAS: 1616703-93-5

Ref. 3D-RPC70393

50mg
779.00 €
100mg
1,135.00 €
Estimated delivery in United States, on Tuesday 14 Jan 2025

Product Information

Name:
Ticagrelor acetate
Description:

Ticagrelor is a drug that is used for the prevention of stroke and death in people who have had a recent heart attack. The active ingredient in this drug is ticagrelor acetate, which is an impurity standard. Ticagrelor acetate selectively binds to the P2Y12 receptor on platelets and blocks the ADP-induced activation of the receptor, preventing platelet aggregation. This chemical has been shown to reduce thrombus formation and improve survival rates after a heart attack. TICAGRELOR ACETATE: Ticagrelor is a drug that is used for the prevention of stroke and death in people who have had a recent heart attack. The active ingredient in this drug is ticagrelor acetate, which is an impurity standard. Ticagrelor acetate selectively binds to the P2Y12 receptor on platelets and blocks the ADP-induced activation of the receptor,

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
564.6 g/mol
Formula:
C25H30F2N6O5S
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-RPC70393 Ticagrelor acetate

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".